Diana A Alaverdian (Diana Alaverdian)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Top Venues

Drug metabolism and personalized therapy

Epileptic disorders : international epilepsy journal with videotape

City Hospital No. 40

University of Siena (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

City Hospital No. 40

Russia

Biologist

Education History

University of Siena

Italy

PHD :: Medical biotechnologies

Saint Petersburg State University

Russia

MSC :: Genetics and Biotechnology

Publications

Diana A Alaverdian, Anna Margherita Corradi, Bruno Sterlini, Fabio Benfenati, Luca Murru, Maria Passafaro, Jlenia Brunetti, Ilaria Meloni, Francesca Mari, Alessandra Renieri, Elisa Frullanti
Modelling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells. Epileptic disorders : international epilepsy journal with videotape (2023)
Alexander N Chernov, Diana A Alaverdian, Oleg S Glotov, Michael V Talabaev, Stanislav P Urazov, Sergei G Shcherbak, Alessandra Renieri, Elisa Frullanti, Olga Shamova
Related expression of TRKA and P75 receptors and the changing copy number of MYC-oncogenes determine the sensitivity of brain tumor cells to the treatment of the nerve growth factor in combination with cisplatin and temozolomide. Drug metabolism and personalized therapy 35 (4) (2020)
Alexander N Chernov, Diana A Alaverdian, Oleg S Glotov, Michael V Talabaev, Stanislav P Urazov, Sergei G Shcherbak, Alessandra Renieri, Elisa Frullanti, Olga Shamova
Related expression of TRKA and P75 receptors and the changing copy number of MYC-oncogenes determine the sensitivity of brain tumor cells to the treatment of the nerve growth factor in combination with cisplatin and temozolomide. Drug metabolism and personalized therapy (2020)